The emerging arrival of the 40mg Tirzepatide dose represents a potentially groundbreaking advancement in the handling of type 2 diabetes . This drug builds upon the prior success of lower dosages , showing encouraging results in reducing blood glucose readings and supporting weight loss . Clinici